Katja Klein

2.5k total citations
27 papers, 596 citations indexed

About

Katja Klein is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Katja Klein has authored 27 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Virology, 13 papers in Immunology and 8 papers in Infectious Diseases. Recurrent topics in Katja Klein's work include HIV Research and Treatment (16 papers), Immune Cell Function and Interaction (5 papers) and Immunotherapy and Immune Responses (5 papers). Katja Klein is often cited by papers focused on HIV Research and Treatment (16 papers), Immune Cell Function and Interaction (5 papers) and Immunotherapy and Immune Responses (5 papers). Katja Klein collaborates with scholars based in United Kingdom, United States and Canada. Katja Klein's co-authors include Robin J. Shattock, Jamie F. S. Mann, Viviana Buffa, Alberto Pérez-Bouza, Tamara Glaser, Oliver Brüstle, Paul F. McKay, Lucia Fischetti, Julian K‐C. and Audrey Y‐H. Teh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Katja Klein

25 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katja Klein United Kingdom 16 265 215 203 127 111 27 596
Sandesh Subramanya United States 14 179 0.7× 104 0.5× 474 2.3× 89 0.7× 119 1.1× 19 819
Candido Alicea United States 21 848 3.2× 447 2.1× 337 1.7× 163 1.3× 243 2.2× 38 1.3k
Dorian McIlroy France 19 848 3.2× 327 1.5× 405 2.0× 124 1.0× 133 1.2× 32 1.3k
Rafaela Argnani Italy 15 116 0.4× 43 0.2× 287 1.4× 57 0.4× 387 3.5× 24 781
Michael D. Eisenbraun United States 11 591 2.2× 78 0.4× 232 1.1× 117 0.9× 171 1.5× 15 874
Nikaïa Smith France 15 313 1.2× 71 0.3× 154 0.8× 120 0.9× 205 1.8× 31 754
Wibke Bayer Germany 17 340 1.3× 91 0.4× 271 1.3× 107 0.8× 160 1.4× 47 736
Curtis Dobrowolski United States 21 378 1.4× 631 2.9× 634 3.1× 374 2.9× 122 1.1× 27 1.3k
Nidia M. Modesti Argentina 12 206 0.8× 111 0.5× 298 1.5× 51 0.4× 53 0.5× 19 579
Amaya Iparraguirre United States 7 473 1.8× 48 0.2× 140 0.7× 65 0.5× 142 1.3× 7 757

Countries citing papers authored by Katja Klein

Since Specialization
Citations

This map shows the geographic impact of Katja Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katja Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katja Klein more than expected).

Fields of papers citing papers by Katja Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katja Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katja Klein. The network helps show where Katja Klein may publish in the future.

Co-authorship network of co-authors of Katja Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Katja Klein. A scholar is included among the top collaborators of Katja Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katja Klein. Katja Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bigotti, Maria Giulia, Katja Klein, Esther S. Gan, et al.. (2024). The α-dystroglycan N-terminus is a broad-spectrum antiviral agent against SARS-CoV-2 and enveloped viruses. Antiviral Research. 224. 105837–105837.
3.
Simonetti, Boris, James L. Daly, Lorena Simón‐Gracia, et al.. (2022). ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. Proceedings of the National Academy of Sciences. 119(25). e2201980119–e2201980119. 18 indexed citations
4.
Mann, Jamie F. S., et al.. (2021). Blocking T‐cell egress with FTY720 extends DNA vaccine expression but reduces immunogenicity. Immunology. 165(3). 301–311. 2 indexed citations
5.
Mann, Jamie F. S., Katja Klein, Paul F. McKay, et al.. (2020). A targeted reactivation of latent HIV-1 using an activator vector in patient samples from acute infection. EBioMedicine. 59. 102853–102853. 10 indexed citations
6.
Klein, Katja, Gabrielle Nickel, Immaculate Nankya, et al.. (2018). Higher sequence diversity in the vaginal tract than in blood at early HIV-1 infection. PLoS Pathogens. 14(1). e1006754–e1006754. 17 indexed citations
7.
Klein, Katja, Paul F. McKay, Deborah King, et al.. (2018). A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system. npj Vaccines. 3(1). 2–2. 17 indexed citations
8.
Bagaya, Bernard S., Gabrielle Nickel, Yuejin Li, et al.. (2017). An in vitro Model to Mimic Selection of Replication-Competent HIV-1 Intersubtype Recombination in Dual or Superinfected Patients. Journal of Molecular Biology. 429(14). 2246–2264. 4 indexed citations
9.
Lee, Sangkyun, Kunyu Wu, Anthony Mills, et al.. (2016). First Phase I human clinical trial of a killed whole-HIV-1 vaccine: demonstration of its safety and enhancement of anti-HIV antibody responses. Retrovirology. 13(1). 82–82. 22 indexed citations
10.
Veazey, Ronald S., Asna A. Siddiqui, Katja Klein, et al.. (2015). Evaluation of mucosal adjuvants and immunization routes for the induction of systemic and mucosal humoral immune responses in macaques. Human Vaccines & Immunotherapeutics. 11(12). 2913–2922. 15 indexed citations
11.
Stieh, Daniel J, Deborah King, Katja Klein, et al.. (2015). Discrete partitioning of HIV-1 Env forms revealed by viral capture. Retrovirology. 12(1). 81–81. 13 indexed citations
12.
Paul, Matthew J., Rajko Reljić, Katja Klein, et al.. (2014). Characterization of a plant-produced recombinant human secretory IgA with broad neutralizing activity against HIV. mAbs. 6(6). 1585–1597. 45 indexed citations
13.
Stieh, Daniel J, Deborah King, Katja Klein, et al.. (2014). Aggregate complexes of HIV-1 induced by multimeric antibodies. Retrovirology. 11(1). 78–78. 24 indexed citations
14.
Klein, Katja, Jamie F. S. Mann, Paul Rogers, & Robin J. Shattock. (2014). Polymeric penetration enhancers promote humoral immune responses to mucosal vaccines. Journal of Controlled Release. 183. 43–50. 22 indexed citations
15.
Tregoning, John S., Viviana Buffa, Anna Oszmiana, et al.. (2013). A “Prime-Pull” Vaccine Strategy Has a Modest Effect on Local and Systemic Antibody Responses to HIV gp140 in Mice. PLoS ONE. 8(11). e80559–e80559. 18 indexed citations
16.
Mann, Jamie F. S., et al.. (2013). Pulmonary delivery of DNA vaccine constructs using deacylated PEI elicits immune responses and protects against viral challenge infection. Journal of Controlled Release. 170(3). 452–459. 33 indexed citations
17.
Buffa, Viviana, Katja Klein, Lucia Fischetti, & Robin J. Shattock. (2012). Evaluation of TLR Agonists as Potential Mucosal Adjuvants for HIV gp140 and Tetanus Toxoid in Mice. PLoS ONE. 7(12). e50529–e50529. 50 indexed citations
18.
Mann, Jamie F. S., Daniel J Stieh, Katja Klein, et al.. (2011). Transferrin conjugation confers mucosal molecular targeting to a model HIV-1 trimeric gp140 vaccine antigen. Journal of Controlled Release. 158(2). 240–249. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026